Multimodality treatment of esophagus cancer: current status and future perspectives in the United States

Esophagus ◽  
2010 ◽  
Vol 7 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Arlene A. Forastiere
2017 ◽  
Vol 74 ◽  
pp. 1300-1313 ◽  
Author(s):  
Marcus Lehmann ◽  
Farid Karimpour ◽  
Clifford A. Goudey ◽  
Paul T. Jacobson ◽  
Mohammad-Reza Alam

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Kevin C. J. Yuen

Growth hormone deficiency (GHD) is a well-recognized clinical syndrome in adults. However, due to the high frequency of normal serum IGF-I levels in hypopituitary adults with GHD, it is now widely accepted that despite normal levels of total IGF-I, adults clinically suspected with GHD within the appropriate clinical setting must undergo GH provocative testing to confirm its diagnosis. Although the insulin tolerance test (ITT) is labor intensive, contraindicated in the elderly and in adults with seizure disorders and ischemic heart disease, can be unpleasant for the patient, and is potentially hazardous, this test remains the gold standard test for the biochemical demonstration of GHD in adults. In contrast, with the unavailability of the GHRH and arginine test as the alternative test to the ITT in the United States since 2008, the glucagon stimulation test (GST) has since been increasingly used in the United States because of its availability, reproducibility, safety, lack of influence by gender and hypothalamic cause of GHD, and relatively few contraindications. In this paper, we discuss our recommendations in performing this test, the potential drawbacks in conducting and caveats in interpreting this test, and its future perspectives.


2019 ◽  
Vol 02 (03) ◽  
Author(s):  
Sherif Aly ◽  
Allan Stolarski ◽  
Patrick O’Neal ◽  
Edward Whang ◽  
Gentian Kristo

Harmful Algae ◽  
2021 ◽  
pp. 101975
Author(s):  
Donald M. Anderson ◽  
Elizabeth Fensin ◽  
Christopher J. Gobler ◽  
Alicia E. Hoeglund ◽  
Katherine A. Hubbard ◽  
...  

Author(s):  
Mohammad Reza Davahli ◽  
Krzysztof Fiok ◽  
Waldemar Karwowski ◽  
Awad M. Aljuaid ◽  
Redha Taiar

The COVID-19 pandemic has had unprecedented social and economic consequences in the United States. Therefore, accurately predicting the dynamics of the pandemic can be very beneficial. Two main elements required for developing reliable predictions include: (1) a predictive model and (2) an indicator of the current condition and status of the pandemic. As a pandemic indicator, we used the effective reproduction number (Rt), which is defined as the number of new infections transmitted by a single contagious individual in a population that may no longer be fully susceptible. To bring the pandemic under control, Rt must be less than one. To eliminate the pandemic, Rt should be close to zero. Therefore, this value may serve as a strong indicator of the current status of the pandemic. For a predictive model, we used graph neural networks (GNNs), a method that combines graphical analysis with the structure of neural networks. We developed two types of GNN models, including: (1) graph-theory-based neural networks (GTNN) and (2) neighborhood-based neural networks (NGNN). The nodes in both graphs indicated individual states in the US states. While the GTNN model’s edges document functional connectivity between states, those in the NGNN model link neighboring states to one another. We trained both models with Rt numbers collected over the previous four days and asked them to predict the following day for all states in the USA. The performance of these models was evaluated with the datasets that included Rt values reflecting conditions from 22 January through 26 November 2020 (before the start of COVID-19 vaccination in the USA). To determine the efficiency, we compared the results of two models with each other and with those generated by a baseline Long short-term memory (LSTM) model. The results indicated that the GTNN model outperformed both the NGNN and LSTM models for predicting Rt.


2016 ◽  
Vol 214 (1) ◽  
pp. S339-S340
Author(s):  
Dotun Ogunyemi ◽  
Alma Aurioles ◽  
Rob Olson ◽  
Nathaniel Sugiyama ◽  
Ray Bahado-Singh

1993 ◽  
Vol 57 (2) ◽  
pp. 424
Author(s):  
H. Lee Stribling ◽  
John J. Mayer ◽  
I. Lehr Brisbin

2005 ◽  
Vol 16 (07) ◽  
pp. 410-418 ◽  
Author(s):  
Dennis Van Vliet

The members of the profession of audiology often express concern that the services and products that have been developed to provide benefit to the hearing impaired are not sought after or delivered to the majority of those diagnosed with hearing loss. A critical look at the status quo of hearing care delivery in the United States is needed to verify this assumption and to develop strategies to improve the situation. A key concern is the lack of a comprehensive high-quality scientific database upon which to build continuous improvements in the effectiveness of the services and products that are provided to the hearing impaired.


Urology ◽  
2014 ◽  
Vol 84 (4) ◽  
pp. 743-747 ◽  
Author(s):  
Bruce Slaughenhoupt ◽  
Oreoluwa Ogunyemi ◽  
Maria Giannopoulos ◽  
Christina Sauder ◽  
Glen Leverson

Sign in / Sign up

Export Citation Format

Share Document